# Prima Mente

> Biological foundation models for understanding complex disease.

## Why it is interesting

The investment thesis depends on whether model outputs yield useful biological evidence and eventually commercial value. Computational findings should remain separate from clinical validation.

## Profile

- **Latest funding:** Not publicly disclosed
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** Not publicly disclosed
- **Stage:** other
- **Status:** private
- **Industries:** ai-ml, healthtech, deep-tech
- **Coverage:** full
- **Last updated:** 2026-10-16T13:22:44.924Z

## Key facts

- NVIDIA investment planned and amount undisclosed as of October 13, 2026 primary announcement.

## Related articles

- https://venturecapitaltracker.com/nvidia-250m-uk-compute-pledge-planned-startup-investments

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 16, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/prima-mente